A Double-blind, Randomized Conversion to Monotherapy Study to Evaluate the Efficacy and Safety of Brivaracetam in Subjects (≥ 16 to 75 Years Old) With Partial Onset Seizures
Clinical trial NCT00698581 · TERMINATED
Trial details
- NCT number
- NCT00698581
- Sponsor
- UCB Pharma
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2008-08-01
- Primary completion
- 2010-01-01
- Enrollment
- 88
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.